Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201404050 Principal Investigator: Adkins, Douglas
Title: Phase II multicenter randomized, double blind, placebo controlled study assessing the efficacy of buparlisib (BKM120) plus paclitaxel vs. placebo plus paclitaxel in patients with platinum pre-treated recurrent or metastatic head and neck squamous cell carcinoma
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out if the drug buparlisib in combination with paclitaxel is safe and has beneficial effects in patients who have recurrent or metastatic head and neck squamous cell carcinoma.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)